Nuwellis Inc (NUWE) Stock Price, Quote & News - Mboum

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; a...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

Mackie2020 Jun. 25 at 2:13 AM

$NUWE a special gift for a special someone….

0 · Reply

MCapitalJ Jun. 24 at 7:10 PM

$NUWE wait until after the split to add anything

2 · Reply

The_Gambl3r Jun. 24 at 7:10 PM

$NUWE Pretty Please

0 · Reply

ManuelFromGermany Jun. 24 at 7:05 PM

$NUWE $0.06 is the golden zone for NUWE stock. .

0 · Reply

The_Gambl3r Jun. 24 at 6:58 PM

$NUWE Will see this through no matter what at this point.. still. Minimal loss size wise probably compared to many longs but yeah.. I’ll be here lurking. GL to the new CEO. Not a fan of Erb still being around though. But really, don’t think even the company matters with this ticker. There is an agenda here.

1 · Reply

Lyn30 Jun. 24 at 6:58 PM

$NUWE 😂 60M plus 20M This type of company shouldn’t allowed imo

0 · Reply

TwongStocks Jun. 24 at 6:52 PM

$NUWE Equity Corporate Actions Alert #2026 - 431 Information Regarding the Reverse Stock Split and CUSIP Number Change for Nuwellis, Inc. (NUWE) https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2026-431 Nuwellis, Inc. (NUWE) will effect a one-for-thirty five (1-35) reverse split of its common stock. The reverse stock split will become effective on Friday, June 26, 2026. In conjunction with the reverse split, the CUSIP number will change to 67113Y801.

0 · Reply

Lehameri Jun. 24 at 6:38 PM

$NUWE this is messed up. I dont think there is a world where longs will profit here.

1 · Reply

Bigwinner75 Jun. 24 at 5:44 PM

$NUWE disappointed

0 · Reply

Abelssss Jun. 24 at 5:19 PM

$NUWE Eric Lindros

0 · Reply

Latest News on NUWE

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Jun 24, 2026, 8:30 AM EDT - 15 hours ago

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

2026-06-18T12:51:14.000Z - 6 days ago

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Jun 18, 2026, 8:30 AM EDT - 6 days ago

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

2026-06-16T12:50:42.000Z - 8 days ago

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Jun 16, 2026, 8:30 AM EDT - 8 days ago

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Nuwellis expands collaboration with South Carolina healthcare system

2026-06-10T12:50:10.000Z - 14 days ago

Nuwellis expands collaboration with South Carolina healthcare system

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Jun 10, 2026, 8:30 AM EDT - 14 days ago

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

Jun 8, 2026, 9:46 PM EDT - 16 days ago

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

Nuwellis 20M share secondary priced at 30c

2026-06-05T12:56:35.000Z - 19 days ago

Nuwellis 20M share secondary priced at 30c

Nuwellis Announces Pricing of $6 Million Public Offering

Jun 5, 2026, 8:30 AM EDT - 19 days ago

Nuwellis Announces Pricing of $6 Million Public Offering

Nuwellis Registration statement: Registration filing

Jun 4, 2026, 8:00 AM EDT - 20 days ago

Nuwellis Registration statement: Registration filing

Nuwellis Slides: Investor presentation

Jun 2, 2026, 7:00 AM EDT - 22 days ago

Nuwellis Slides: Investor presentation

Nuwellis Registration statement: Registration filing

May 29, 2026, 8:00 AM EDT - 26 days ago

Nuwellis Registration statement: Registration filing

Nuwellis files to sell 4.85M shares of common stock, warrants

2026-05-22T21:15:44.000Z - 4 weeks ago

Nuwellis files to sell 4.85M shares of common stock, warrants

Nuwellis Registration statement: Registration filing

May 22, 2026, 8:00 AM EDT - 4 weeks ago

Nuwellis Registration statement: Registration filing

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

2026-05-14T14:09:24.000Z - 5 weeks ago

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

May 14, 2026, 8:30 AM EDT - 5 weeks ago

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

Nuwellis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 6 weeks ago

Nuwellis Earnings Call Transcript: Q1 2026

Nuwellis Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 6 weeks ago

Nuwellis Earnings release: Q1 2026

Nuwellis Quarterly report: Q1 2026

May 12, 2026, 9:00 AM EDT - 6 weeks ago

Nuwellis Quarterly report: Q1 2026

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

May 12, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

May 5, 2026, 8:00 AM EDT - 7 weeks ago

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

Apr 29, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

2026-04-28T13:19:54.000Z - 2 months ago

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Nuwellis Announces Aquadex Software Update

Apr 21, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Aquadex Software Update

Nuwellis announces return of three former team members

2026-04-16T12:51:56.000Z - 2 months ago

Nuwellis announces return of three former team members

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Apr 16, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

Apr 9, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

Nuwellis expands commercial footprint with new South Texas territory

2026-04-07T13:45:21.000Z - 2 months ago

Nuwellis expands commercial footprint with new South Texas territory

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Apr 7, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Nuwellis Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Proxy statement: Proxy filing

Nuwellis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Proxy statement: Proxy filing

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Mar 31, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Nuwellis completes acquisition of Rendiatech

2026-03-17T12:27:39.000Z - 3 months ago

Nuwellis completes acquisition of Rendiatech

Nuwellis Completes Acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Completes Acquisition of Rendiatech

Nuwellis Earnings Call Transcript: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 3 months ago

Nuwellis Earnings Call Transcript: Q4 2025

Nuwellis Earnings release: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 3 months ago

Nuwellis Earnings release: Q4 2025

Nuwellis Annual report: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 3 months ago

Nuwellis Annual report: Q4 2025

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

2026-03-10T12:21:07.000Z - 3 months ago

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026, 8:15 AM EDT - 3 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Nuwellis appoints Goldstein as Director of Clinical Strategy

2026-03-05T13:26:40.000Z - 3 months ago

Nuwellis appoints Goldstein as Director of Clinical Strategy

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Mar 5, 2026, 8:00 AM EST - 3 months ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Nuwellis appoints McDonald, Emerson to board of directors

2026-02-26T13:12:57.000Z - 4 months ago

Nuwellis appoints McDonald, Emerson to board of directors

Nuwellis Appoints David A. McDonald and Martin J.

Feb 26, 2026, 8:00 AM EST - 4 months ago

Nuwellis Appoints David A. McDonald and Martin J.

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Feb 24, 2026, 8:00 AM EST - 4 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Nuwellis Slides: Investor presentation

Feb 17, 2026, 6:00 AM EST - 4 months ago

Nuwellis Slides: Investor presentation

Nuwellis Registration statement: Registration Filing

Feb 4, 2026, 7:00 AM EST - 5 months ago

Nuwellis Registration statement: Registration Filing

Nuwellis files to sell 4.28M shares of common stock for holders

2026-02-04T11:11:26.000Z - 5 months ago

Nuwellis files to sell 4.28M shares of common stock for holders

Nuwellis appoints Schultz as Chief Financial Officer

2026-01-30T13:25:28.000Z - 5 months ago

Nuwellis appoints Schultz as Chief Financial Officer

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 5 months ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis announces $5M private placement, warrant inducement transaction

2026-01-29T21:45:37.000Z - 5 months ago

Nuwellis announces $5M private placement, warrant inducement transaction

Nuwellis to acquire Rendiatech, terms not disclosed

2026-01-29T21:40:34.000Z - 5 months ago

Nuwellis to acquire Rendiatech, terms not disclosed

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:36 PM EST - 5 months ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 29, 2026, 4:35 PM EST - 5 months ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Here’s Why Nuwellis Stock (NUWE) Rocketed Today

2026-01-27T14:00:45.000Z - 5 months ago

Here’s Why Nuwellis Stock (NUWE) Rocketed Today

Nuwellis Announces Changes to Board of Directors

Jan 23, 2026, 4:40 PM EST - 5 months ago

Nuwellis Announces Changes to Board of Directors

Nuwellis announces issuance of new U.S. patent on extracorporeal therapy

2026-01-06T13:36:04.000Z - 6 months ago

Nuwellis announces issuance of new U.S. patent on extracorporeal therapy

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Jan 6, 2026, 8:15 AM EST - 6 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 9, 2025, 8:15 AM EST - 7 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Dec 4, 2025, 8:15 AM EST - 7 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis Earnings Call Transcript: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Earnings Call Transcript: Q3 2025

Nuwellis Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Quarterly report: Q3 2025

Nuwellis Earnings release: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Earnings release: Q3 2025

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 12, 2025, 8:15 AM EST - 8 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nov 10, 2025, 9:00 AM EST - 8 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 8 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 9 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 9 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 10 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 10 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 10 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 10 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 11 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis Earnings Call Transcript: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Earnings Call Transcript: Q2 2025

Nuwellis Quarterly report: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Quarterly report: Q2 2025

Nuwellis Earnings release: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Earnings release: Q2 2025

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 11 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 11 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 11 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 1 year ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 1 year ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 1 year ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 1 year ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Mackie2020 Jun. 25 at 2:13 AM

$NUWE a special gift for a special someone….

0 · Reply

MCapitalJ Jun. 24 at 7:10 PM

$NUWE wait until after the split to add anything

2 · Reply

The_Gambl3r Jun. 24 at 7:10 PM

$NUWE Pretty Please

0 · Reply

ManuelFromGermany Jun. 24 at 7:05 PM

$NUWE $0.06 is the golden zone for NUWE stock. .

0 · Reply

The_Gambl3r Jun. 24 at 6:58 PM

$NUWE Will see this through no matter what at this point.. still. Minimal loss size wise probably compared to many longs but yeah.. I’ll be here lurking. GL to the new CEO. Not a fan of Erb still being around though. But really, don’t think even the company matters with this ticker. There is an agenda here.

1 · Reply

Lyn30 Jun. 24 at 6:58 PM

$NUWE 😂 60M plus 20M This type of company shouldn’t allowed imo

0 · Reply

TwongStocks Jun. 24 at 6:52 PM

$NUWE Equity Corporate Actions Alert #2026 - 431 Information Regarding the Reverse Stock Split and CUSIP Number Change for Nuwellis, Inc. (NUWE) https://www.nasdaqtrader.com/TraderNews.aspx?id=eca2026-431 Nuwellis, Inc. (NUWE) will effect a one-for-thirty five (1-35) reverse split of its common stock. The reverse stock split will become effective on Friday, June 26, 2026. In conjunction with the reverse split, the CUSIP number will change to 67113Y801.

0 · Reply

Lehameri Jun. 24 at 6:38 PM

$NUWE this is messed up. I dont think there is a world where longs will profit here.

1 · Reply

Bigwinner75 Jun. 24 at 5:44 PM

$NUWE disappointed

0 · Reply

Abelssss Jun. 24 at 5:19 PM

$NUWE Eric Lindros

0 · Reply

lolouis Jun. 24 at 5:15 PM

$NUWE why down?

0 · Reply

rayankhader Jun. 24 at 3:25 PM

$NUWE adding more here Watch when the volume come 👀💎⏳

1 · Reply

The_Gambl3r Jun. 24 at 3:18 PM

$NUWE Please?

1 · Reply

The_Gambl3r Jun. 24 at 3:13 PM

$NUWE “None” please blow them up. Thx.

1 · Reply

416Area Jun. 24 at 3:07 PM

$NUWE when insiders have no skin in the game, you know what to expect...0.2% insider ownership

0 · Reply

done84 Jun. 24 at 2:36 PM

$NUWE such a scam.🖕🖕🖕

0 · Reply

Longintactandinminent Jun. 24 at 2:28 PM

$NUWE when mo telling people 130 coming and 400 lmao

1 · Reply

rayankhader Jun. 24 at 2:09 PM

$NUWE hmmmm 👀👀

0 · Reply

yenkins Jun. 24 at 2:02 PM

$NUWE $2.76-3.30

0 · Reply

yenkins Jun. 24 at 1:59 PM

1 · Reply

Dominicstocks Jun. 24 at 1:50 PM

$NUWE This is a huge scam really I’m disappointed In the SEC for letting this go on

0 · Reply

Desihu Jun. 24 at 1:42 PM

$NUWE what dumb retards running these companies and country 🤣

0 · Reply